Showing posts with label research. Show all posts
Showing posts with label research. Show all posts

World Pharmaceutical and Biopharmaceutical Market, 2010-2015 now available at ReportsnReports

What Will The Pharmaceutical Market Look Like in the Next Five Years?
This research undertaking is the result of a detailed analysis of the late stage R&D pipeline of the 50 top companies in pharmaceuticals, the companies that produce the lion's share of revenues. While the report looks at the entire pipeline to 2015, a key focus of the report is the increasing role of biopharmaceutical products. The growing interest in biotechnology development has transitioned the pharmaceutical industry to biopharmaceuticals in less than a decade. Companies such as Pfizer, Merck and Novartis have been unable to ignore the benefits of investing in biotechnology and have focused on a pipeline in this direction through strategic acquisitions and partnerships with biotech companies and/or through their own in-house research efforts.
Companies such as Amgen and Genzyme, which specialize in biotechnology, are now competing with a growing number of companies and the lines between pharmaceutical and biotechnology specialty companies are becoming more blended; which is a trend expected to continue to grow.
This Kalorama Information market research report, The World Pharmaceutical and Biopharmaceutical Market, 2010-2015 (Pipeline Analysis of the Top 50 Companies) captures these trends, extracting sales for all pharmaceutical and biopharmaceutical products (excluding prophylactic vaccines) and providing estimates and forecasts of the world biopharma market.
CHAPTER ONE: EXECUTIVE SUMMARY
Introduction
Scope and Methodology
Potential Market Opportunity
Issues and Trends Affecting Market
Leading Compan
CHAPTER TWO: INTRODUCTION
Global Pharmaceutical Market
Pharmaceutical Research & Development Overview
Clinical Trial Costs
CHAPTER THREE: ISSUES AND TRENDS
Biotechnology Drug Development
Orphan Drugs
Fast Track Drug Status
Other Accelerated Methods for Drug Approval
Pharmaceutical Regulatory Exclusivity
Pediatric Extensions
Biopharmaceutical Industry—Biosimilar (Biogeneric) Development and Exclusivity Legislation
Aging Population
Mergers, Acquisitions, and Collaborations
Contributors To R&D Success
R&D Spending
The Role of Contract Research Organizations
Sustainability in a changing Pharmaceutical Industry
CHAPTER FOUR: WORLDWIDE PHARMACEUTICAL INDUSTRY LEADERS
Introduction
Pfizer, Inc./Wyeth (merged in 2009)
Overview
Financial Performance and Investments
Late Stage Pipeline
Merck & Co., Inc.
Overview
Financial Performance and Investments
Late Stage Pipeline
Novartis AG
Overview
Financial Performance and Investments
Late Stage Pipeline
Roche Ltd.
Overview
Financial Performance and Investments
Late Stage Pipeline
Sanofi-Aventis
Overview
Financial Performance and Investments
Late Stage Pipeline
AstraZeneca plc
Overview
Financial Performance and Investments
Late Stage Pipeline
GlaxoSmithKline plc
Overview
Financial Performance and Investments
Late Stage Pipeline
Johnson & Johnson
Overview
Financial Performance and Investments
Late Stage Pipeline
Eli Lilly & Company
Overview
Financial Performance and Investments
Late Stage Pipeline
Bristol-Myers Squibb Company
Overview
Financial Performance and Investments
Late Stage Pipeline
Abbott Laboratories
Overview
Financial Performance and Investments
Late Stage Pipeline
Takeda Pharmaceutical Co., Ltd.
Overview
Financial Performance and Investments
Late Stage Pipeline
Bayer AG
Overview
Financial Performance and Investments
Late Stage Pipeline
Amgen, Inc.
Overview
Financial Performance and Investments
Late Stage Pipeline
Boehringer Ingelheim GmbH
Overview
Financial Performance and Investments
Late Stage Pipeline
TEVA Pharmaceutical Industries, Ltd.
Overview
Financial Performance and Investments
Late Stage Pipeline
Astellas
Overview
Financial Performance and Investments
Late Stage Pipeline
Daiichi Sankyo
Overview
Financial Performance and Investments
Late Stage Pipeline
Novo Nordisk
Overview
Financial Performance and Investments
Late Stage Pipeline
Eisai
Overview
Financial Performance and Investments
Late Stage Pipeline
CHAPTER FIVE: COMPANIES OF INTEREST
Introduction
Otsuka
Late Stage Pipeline
Merck KGaA
Late Stage Pipeline
Gilead Sciences
Late Stage Pipeline
Mylan
Pipeline
Baxter International
Late Stage Pipeline
Chugai Pharmaceutical Company, Ltd.
Late Stage Pipeline
Mitsubishi Tanabe
Late Stage Pipeline
Servier, Les Laboratories
Pipeline
UCB SA
Late Stage Pipeline
Allergan
Late Stage Pipeline
Forest Laboratories
Late Stage Pipeline
Nycomed International
Late Stage Pipeline
Genzyme Corporation
Late Stage Pipeline
Biogen Idec
Late Stage Pipeline
Hospira
Late Stage Pipeline
Watson
Pipeline
CSL Limited
Late Stage Pipeline
Alcon
Late Stage Pipeline
Shire
Late Stage Pipeline
Celgene Corporation
Late Stage Pipeline
Lundbeck
Late Stage Pipeline
Shionogi & Co., Ltd.
Late Stage Pipeline
Menarini Group
Late Stage Pipeline
Dainippon Sumitomo Pharma, Co., Ltd.
Late Stage Pipeline
Cephalon
Late Stage Pipeline
Actelion
Late Stage Pipeline
Procter & Gamble
Endo Pharmaceuticals
Late Stage Pipeline
Ono Pharmaceutical Co.
Late Stage Pipeline
Purdue Pharma
Late Stage Pipeline
CHAPTER SIX: MARKET FORECAST
Overview
Company Analysis
Pipeline Snapshot: Top 50 Companies
Current Market Value
Market Forecast
CHAPTER SEVEN: BIOPHARMACEUTICAL MARKET
Biopharmaceutical Companies
Biopharmaceutical Market Forecast
ABBREVIATIONS
Browse all : Pharmaceuticals
Browse all : Kalorama Information
Browse all : Newly Published
Related Reports :
About Us:
ReportsnReports  is comprising of an online library of 50,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites.
Our client list boasts of almost all well-known publishers of such reports across the globe. We, as a third party reseller of market research reports employ number of marketing tools such as press releases, email-marketing and effective search engine optimization technique to drive revenues for our clients.
Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004

Read More
Posted by Unknown on
categories: , , , , , , , , |

Worldwide Market for In Vitro Diagnostic Tests, 7th Edition now available at ReportsnReports

Original Source : Vitro Diagnostic Market

In seven best-selling editions, Shara Rosen has provided a total view of every aspect of the market for in vitro diagnostic (IVD) testing in one complete volume. The report, The Worldwide Market for In Vitro Diagnostic Tests, stands as a testament to the Kalorama methodology. Real industry knowledge combined with an exhaustive review of the medical, business, and company literature. A discovery of the trends that are impacting the industry now, and a realistic forecast five years into the future for companies already participating in or considering entry into this growing industry. The idea behind Kalorama's unique report is that the entire market can be captured in one volume and business planners can use it as a key reference. Published every two years, this volume includes all of the major segments of clinical lab testing, including:
Point of Care (POC), (Professional and Self-Testing)
Core Lab (General Chemistries, Workstations, Analyzers)
Immunoassays (Blood Gases, Urinalysis, Critical Care)
Molecular Assays (Infectious Disease, Blood Screening, Inherited Diseases, Oncology, Pharmacodiagnostics, Tissue Typing, Prenatal)
Hematology
Coagulation (Lab-Based, POC, Genetic Markers)
Microbiology and Virology
Blood Banking (Grouping, Immunoassay Screens, NAT Screens)
Histology and Cytology (Pap, ISH, IHC, traditional non-pap, HPV)
For each of these sections, Shara Rosen reviews the key products dominating the market segment, the innovations that are occurring, trends that are impacting the segment. Market size, and forecast and market share are provided; and a geographic share of the segment is provided where possible. Changes in technology development, regulatory and reimbursement issues, clinical care, and business environments are discussed. Current market is provided for 2009; projections are made through 2014.
Kalorama Information’s Report - ‘The Bible of the IVD Industry’
Many of the top IVD companies use this product for business planning, which means that this volume can provide a uniform standard for in vitro diagnostic market numbers. These are the numbers that it is very likely competitive companies will be using in their planning.
This 800+ page edition greatly expands coverage of the field and tracks the most important developments. Expanded or added in this edition are sections on:
The Impact of US Health Care Reform
The Spread of Wireless Diagnostics
New Screening Guidelines and Market Impact
Chronic vs. Infectious Disease
Strange Bedfellows? An Update on the IVD Industry Consolidation
The Continued Molecularization of Devices
The Current Economic Situation: Recession: Post-Recession?
Non-Invasive Sampling
PGx and SNP Testing
The Dynamic Core Lab
IVD and the Promise of Personalized Medicine
Update on Regulation of Novel Devices
Focus on the Continued Fight against Nosocomial Infections
Where Molecular Diagnostics Stands Today
Innovations in Blood Banking
Companies on the Move, and Those in Decline
Histology/Cytology innovations; the role of FISH testing.
In addition, there are now profiles of established and emerging players in IVD, more than 200 companies, from the top tier to the dominant middle, to the companies to watch.

Table Of contents
CHAPTER ONE: EXECUTIVE SUMMARY
Introduction -Doing More with Less
Scope and Methodology
Size and Growth of the Market
Regional Breakout - Major Countries
Regional Breakout- Emerging Countries
IVD Market Growth Indicators
Lean Industry
Group Purchasing
Healthcare Reform
Aging Population
Emerging Markets
Predicted Changes in the IVD Market
Top Companies
Market Trends
Human Genome Project
Remote Monitoring
Development of IVD Product Choices
Educated Consumers
Reimbursement
Need to Document Home Care Benefits

CHAPTER TWO: INTRODUCTION
New Report Design
Note on Acquired Companies
Lab Medicine Disciplines and Applications
Definitions
Market Analysis of IVD Market Segments
The Big Get Bigger
Licenses and Collaboration agreements
Test Services
Top Suppliers and Niche Players
Laggards
Point of View
A Note on 6th Edition and 7th Edition Variances

CHAPTER THREE: OVERVIEW OF GLOBAL IN VITRO DIAGNOSTIC MARKETS
Background
Population and Disease Demographics, Worldwide
Regional Segments of the World IVD Market and IVD Market Evolution
Latin American IVD Sales, 2009 and 2014 ($ million) Special Topics
Special Topics
Initiatives to Support Healthcare Delivery, Worldwide
China and India - Contrast and Compare
India
World Demand for IVD Tests and Services
Insurance Costs, Worldwide
An Overview of Medical Tourism
Specific Country Information
The United States
US Healthcare Reform
Japan
Europe
Denmark
Poland
China
India

CHAPTER FOUR: TRENDS AND INNOVATION
The Economics of Healthcare in Economic Stress
IVD in Recessionary Time
Hospital Market Outlook
Health Care Reform
EMR Update
Patients Seek Test Results
Status of EMR Conversion
Wireless Connectivity and Healthcare Efficiencies
IVD Wireless Applications
Connectivity Imperative for POC devices
RALS
Wireless Apps Everywhere
Consumer Reaction to Wireless Devices
Lab-on-a chip
The search for non-invasive tools
Saliva
Breath
Optical Techniques
Patch Technology
Wearable Sensors/Textiles
Reimbursement Challenges and Developments
The Biomarker Revolution
The In Vivo - In Vitro Diagnostic Service

CHAPTER FIVE: POINT-OF-CARE TESTS
Overview
The Major POC Test Players
DTC - The Myth of Consumerism
Market Analysis
Diabetes Testing - Blood Glucose Monitoring (BGM)
Blood Glucose Self-Testing
Continuous Self Testing
Blood Glucose Testing by Professionals
Diabetes Testing - Glycated Hemoglobin
The Commercial Outlook for POC Tests

CHAPTER SIX: THE CORE LAB
Core Lab Overview
Workstations
Automation
Overview of Chemistry Tests
Market Analysis
Lab-based Chemistries
Critical Care Analysis
Continuous Testing
Urinalysis
The Commercial Outlook for Chemistry Tests

CHAPTER SEVEN: IMMUNOASSAYS
Overview of Immunoassays
Special Topics
The Role of Immunoassays in Disease Management
Market Analysis: Leading Suppliers and Growth Potential
Immunoassay Test Segments — Mature, Maturing and Emerging
Mature Assay Segment
Thyroid Function
Therapeutic drug tests
Anemia
Tox/DAU
Allergy
Maturing Immunoassays
Proteins
Growth Immunoassays
Tumor Markers
Cardiac Markers
Autoimmune
Sepsis
Diabetes
Miscellaneous
Point-of-care OTC and Professional Use
Patient Self-tests (OTC)
Pregnancy Testing
The Commercial Outlook for Immunoassays

CHAPTER EIGHT: MOLECULAR ASSAYS
Overview
Special Topics
The Promise of Personalized Medicine - The $1000 Genome
Molecular Testing Innovation - Sequencing and Mass Spectroscopy
Molecular Testing Innovation: Technology and Players
Market Analysis
Nucleic Acid Tests
Prenatal Chromosome Analysis
Tissue Typing
The Commercial Outlook for Molecular Tests

CHAPTER NINE: HEMATOLOGY
Overview
Decentralized Hematology Testing
Market Analysis: Leading Suppliers
The Commercial Outlook for Hematology Tests

CHAPTER TEN: COAGULATION
Overview of Coagulation and Immunohematology Tests
The PGx Debate
Market Analysis
Lab-based Testing
Genetic Markers of Hypercoagulopathies
Decentralized Coagulation testing - Professional Use
Decentralized Coagulation testing - OTC
Platelet Testing
Leading Suppliers
The Commercial Market for Coagulation Tests

CHAPTER ELEVEN: MICROBIOLOGY AND VIROLOGY
Overview
Special Topics
Infectious Disease Diagnostics in 2009
Global Disease Surveillance
Hospital Acquired Infections (HAIs)
Emerging Organisms and the Globalization of Infectious Diseases
Market Analysis
Supplies
Microbial Identification and Antimicrobial Sensitivity Tests
Blood Culture
Rapid Tests
Immunoassays - Lab Based
Immunoassays - Rapid
TB
HIV
Molecular Tests
Figure 8-4
The Commercial Outlook for Microbiology / Virology Tests

CHAPTER TWELVE: BLOOD BANKING SERVICES
Overview
Blood Management - are all these transfusions good medicine?
Automation to save time
Artificial Blood Products - renewed interest
Market Analysis
Blood Banking Diagnostics Market, 2009 and 2014
Blood Grouping
Immunoassays
Nucleic Acid Testing (NAT) Continues to Grow
The Commercial Outlook for Blood Banking

CHAPTER THIRTEEN: HISTOLOGY AND CYTOLOGY
Overview
Special Topics
The Growth of Histology/Cytology Test Services
Market Analysis
Histology/Cytology
Traditional Stains
Immunohistochemistry and In situ hybridization
Pharmacodiagnostic Histology
Digital Imaging
Tissue Microarrays
Circulating Tumor Cells
Flow Cytometry
The Commercial Outlook for Histology and Cytology Tests

CHAPTER FOURTEEN: COMPANY PROFILES: THE TOP TIER
Abbot Diagnostics
Recent Revenue History
Key Comment
Immunoassays
Core Lab
Hematology
Molecular Histology
Molecular Diagnostics
Infectious Diseases - Molecular
Oncology
Abbott Diabetes Care
Blood Bank
Point of Care
Microbiology
Information Technology

ARKRAY (formerly Kyoto Daiichi)
Recent Revenue History
Key Comment

Becton, Dickinson and Company (BD)
Recent Revenue History ($ million, estimated)
Key Comment
Histology
Flow Cytometry
Molecular
Microbiology
BD Vacutainer Blood Collection Products (Preanalytical Systems)
Beckman Coulter Inc
Recent Revenue History ($ million, * estimated)
Key Comment
Hematology
Core Lab
Automation
Immunoassays
Coagulation
FOB
Flow Cytometry
Image Cytometry
Molecular
Research Markets
The Olympus franchise
Blood Bank
Automation
bioMérieux Inc

ABBREVIATIONS

Browse all : Medical Devices

Browse all : Kalorama Information

Browse all : Newly Published

Related Reports :

Worldwide Market for Cancer Diagnostics, 4th Edition, The

Market for Prescription Dermatological Drugs, 7th Edition, The

U.S. Market for Oral Care Products, 7th Edition, The

Hispanic Latino Market in the U.S. A Generational View, 7th Edition, The

Ethnic Hair, Beauty and Cosmetics Products in the U.S., 7th Edition

About Us:

ReportsnReports  is comprising of an online library of 50,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites.
Our client list boasts of almost all well-known publishers of such reports across the globe. We, as a third party reseller of market research reports employ number of marketing tools such as press releases, email-marketing and effective search engine optimization technique to drive revenues for our clients.

Contact:

Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Website: http://www.reportsnreports.com/
Blog: http://reportsnreports.wordpress.com/

Read More
Posted by Unknown on
categories: , , , , , , |